Cost of managing an episode of relapse in multiple sclerosis in the United States
<p>Abstract</p> <p>Background</p> <p>The purpose of this study was to determine the direct medical US cost of managing multiple sclerosis relapses.</p> <p>Methods</p> <p>Direct data analysis and cost modeling were employed to derive typical resou...
Saved in:
Main Authors: | Ward Alexandra J (Author), O'Brien Judith A (Author), Patrick Amanda R (Author), Caro Jaime (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2003-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost of managing complications resulting from type 2 diabetes mellitus in Canada
by: Patrick Amanda R, et al.
Published: (2003) -
Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada
by: Virender Bhan, et al.
Published: (2023) -
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
by: Mehdi Rezaee, et al.
Published: (2022) -
Vitamin D Status and Multiple Sclerosis Relapse
by: J Gordon Millichap
Published: (2010) -
Relapse Rate in Pediatric-Onset Multiple Sclerosis
by: J Gordon Millichap
Published: (2009)